Pacific Biosciences of California (MEX:PACB) Stock Based Compensation: MXN679 Mil (TTM As of Mar. 2026)


MEX:PACB Pacific Biosciences of California Inc MEX:PACB
53 GF Score
Price MXN27.50
GF Value MXN27.00
! 8 Warning Signs
View Full Analysis

What is Pacific Biosciences of California Stock Based Compensation?

Pacific Biosciences of California MEX:PACB 53 Stock Based Compensation is MXN679 Mil as of Mar. 2026. GuruFocus rates MEX:PACB with a GF Score™ of 53/100 and a GF Value™ of MXN27.00. The stock has 8 warning signs investors should review.

Pacific Biosciences of California's Stock Based Compensation for the three months ended in Mar. 2026 was MXN80 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2026 was MXN679 Mil.

Pacific Biosciences of California Stock Based Compensation Related Terms

Pacific Biosciences of California Stock Based Compensation Historical Data

* Premium members only.

The historical data trend for Pacific Biosciences of California's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pacific Biosciences of California Stock Based Compensation Chart

Pacific Biosciences of California Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Stock Based Compensation
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,504.80 1,532.64 1,224.15 1,481.51 750.26

Pacific Biosciences of California Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Stock Based Compensation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 188.24 223.97 201.49 172.64 80.41
MEX:PACB
53GF Score
Pacific Biosciences of California Inc MEX:PACB
Stock Based Compensation is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Pacific Biosciences of California Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN679 Mil.

What does a Stock Based Compensation of MXN679 Mil mean?
Pacific Biosciences of California (MEX:PACB) has a Stock Based Compensation of MXN679 Mil as of Mar. 2026. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Pacific Biosciences of California and its competitors.
Is Pacific Biosciences of California's Stock Based Compensation too high?
Pacific Biosciences of California's current Stock Based Compensation is MXN679 Mil. Overall, Pacific Biosciences of California has a GF Score™ of 53/100, reflecting its overall financial health beyond just this single metric.
How does Pacific Biosciences of California's Stock Based Compensation compare to KIDS and MOBI?
Pacific Biosciences of California's Stock Based Compensation of MXN679 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Stock Based Compensation for a Medical Devices & Instruments company?
A good Stock Based Compensation depends on the Medical Devices & Instruments industry context. However, Stock Based Compensation should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Stock Based Compensation mean?
A high Stock Based Compensation can signal that a stock is expensive relative to its fundamentals. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Pacific Biosciences of California and its competitors. Pacific Biosciences of California's current Stock Based Compensation is MXN679 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pacific Biosciences of California stock overvalued right now?
Pacific Biosciences of California (MEX:PACB) has a current Stock Based Compensation of MXN679 Mil. The stock's GF Value™ is MXN27.00, compared to a current price of MXN27.50 — trading 1.9% above its estimated fair value. The current Stock Based Compensation is MXN679 Mil. Pacific Biosciences of California's overall GF Score™ is 53/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Stock Based Compensation calculated?
Stock Based Compensation is calculated from a company's financial statements. For Pacific Biosciences of California (MEX:PACB), the current Stock Based Compensation is MXN679 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Pacific Biosciences of California (MEX:PACB) Overvalued in 2026?

Based on GuruFocus' analysis, Pacific Biosciences of California stock appears to be overvalued. The current stock price of MXN27.50 is trading 1.9% above its estimated GF Value™ of MXN27.00.

Key valuation signals for MEX:PACB:

  • Stock Based Compensation: MXN679 Mil
  • GF Value™: MXN27.00 vs. price of MXN27.50 (1.9% above fair value)
  • GF Score™: 53/100 with 8 warning signs

No single metric tells the full story. See the MEX:PACB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Pacific Biosciences of California Business Description

Other Exchanges PACB:USAP09:Germany
Address 1305 O’Brien Drive, Menlo Park, CA, USA, 94025
Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Europe Middle East, and Africa and Asia-Pacific.
53GF Score

Get the complete analysis for MEX:PACB

Stock Based Compensation is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN27.50
Price
MXN27.00
GF Value